EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Debate 2: The Case for Focal External Beam Radiation Therapy Boost Over Brachytherapy Boost for Prostate Cancer

Anna M Dornisch, Tyler M Seibert

Seminars in Radiation Oncology · 2025

DOI: 10.1016/j.semradonc.2025.04.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Radiation Oncology, 2025. Verfasst von Anna M Dornisch und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Brachytherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Biomedical Imaging and Bioengineering, U.S. Department of Defense, Prostate Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modern trials demonstrate excellent outcomes for men with localized prostate cancer treated with radiation therapy. However, some patients experience recurrences, and more than one-third of recurrences are localized to the prostate. Treatment intensification through dose intensification could substantially benefit some patients with localized, unfavorable-risk prostate cancer. Currently, modern phase 3 randomized controlled trials support 2 treatment strategies. ASCENDE-RT evaluated whole-gland LDR brachytherapy boost, and FLAME evaluated a focal external beam radiation therapy (EBRT) boost to MRI-visible lesions. This review compares a FLAME-style EBRT boost vs a LDR brachytherapy boost in terms of oncologic outcomes, toxicity, and feasibility. The FLAME trial demonstrates that an EBRT boost to MRI visible lesions improves local control as well as regional and distant metastasis free survival without a significant increase in toxicity. In contrast, ASCENDE-RT reports an improvement in only biochemical recurrence free survival, and this comes at the expense of increased gastrointestinal and genitourinary toxicity. Beyond efficacy and toxicity, we discuss the challenges to widespread implementation of each technique, as treatment advances are only beneficial if they are available. While both techniques have unique barriers to implementation, we believe addressing the barriers for focal EBRT boost implementation are more addressable. In conclusion, we maintain that available high-level evidence supports a focal EBRT boost over brachytherapy because focal EBRT boost was shown to give a meaningful improvement in oncologic outcomes with minimal impact on quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBrachytherapyHumansMaleNeoplasm Recurrence, LocalRadiotherapy DosageRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA.
  • Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA.; Department of Bioengineering, University of California San Diego, La Jolla, CA.; Department of Radiology, Univers…

Förderung

  • National Institute of Biomedical Imaging and Bioengineering
  • U.S. Department of Defense
  • Prostate Cancer Foundation
  • American Society for Radiation Oncology
  • National Institutes of Health

Zitieren

APA

Dornisch, A. M., & Seibert, T. M. (2025). Debate 2: The Case for Focal External Beam Radiation Therapy Boost Over Brachytherapy Boost for Prostate Cancer. Seminars in Radiation Oncology. https://doi.org/10.1016/j.semradonc.2025.04.005

Vancouver

Dornisch AM, Seibert TM. Debate 2: The Case for Focal External Beam Radiation Therapy Boost Over Brachytherapy Boost for Prostate Cancer. Seminars in Radiation Oncology. 2025. doi:10.1016/j.semradonc.2025.04.005

BibTeX
@article{Dornisch2025,
  author = {Dornisch, Anna M and Seibert, Tyler M},
  title = {Debate 2: The Case for Focal External Beam Radiation Therapy Boost Over Brachytherapy Boost for Prostate Cancer},
  journal = {Seminars in Radiation Oncology},
  year = {2025},
  doi = {10.1016/j.semradonc.2025.04.005}
}
Kostenlos starten →